Literature DB >> 30779207

SCN1A gain of function in early infantile encephalopathy.

Géza Berecki1, Alexander Bryson1, Jan Terhag1, Snezana Maljevic1, Elena V Gazina1, Sean L Hill2, Steven Petrou1,3.   

Abstract

OBJECTIVE: To elucidate the biophysical basis underlying the distinct and severe clinical presentation in patients with the recurrent missense SCN1A variant, p.Thr226Met. Patients with this variant show a well-defined genotype-phenotype correlation and present with developmental and early infantile epileptic encephalopathy that is far more severe than typical SCN1A Dravet syndrome.
METHODS: Whole cell patch clamp and dynamic action potential clamp were used to study T226M Nav 1.1 channels expressed in mammalian cells. Computational modeling was used to explore the neuronal scale mechanisms that account for altered action potential firing.
RESULTS: T226M channels exhibited hyperpolarizing shifts of the activation and inactivation curves and enhanced fast inactivation. Dynamic action potential clamp hybrid simulation showed that model neurons containing T226M conductance displayed a left shift in rheobase relative to control. At current stimulation levels that produced repetitive action potential firing in control model neurons, depolarization block and cessation of action potential firing occurred in T226M model neurons. Fully computationally simulated neuron models recapitulated the findings from dynamic action potential clamp and showed that heterozygous T226M models were also more susceptible to depolarization block.
INTERPRETATION: From a biophysical perspective, the T226M mutation produces gain of function. Somewhat paradoxically, our data suggest that this gain of function would cause interneurons to more readily develop depolarization block. This "functional dominant negative" interaction would produce a more profound disinhibition than seen with haploinsufficiency that is typical of Dravet syndrome and could readily explain the more severe phenotype of patients with T226M mutation. Ann Neurol 2019;85:514-525.
© 2019 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30779207     DOI: 10.1002/ana.25438

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  Case studies in neuroscience: a novel amino acid duplication in the NH2-terminus of the brain sodium channel NaV1.1 underlying Dravet syndrome.

Authors:  Madeline Angus; Colin H Peters; Damon Poburko; Elise Brimble; Emily M Spelbrink; Peter C Ruben
Journal:  J Neurophysiol       Date:  2019-09-18       Impact factor: 2.714

2.  Phenotypic and Genotypic Characteristics of SCN1A Associated Seizure Diseases.

Authors:  Chunhong Chen; Fang Fang; Xu Wang; Junlan Lv; Xiaohui Wang; Hong Jin
Journal:  Front Mol Neurosci       Date:  2022-04-28       Impact factor: 5.639

3.  Somatostatin-Positive Interneurons Contribute to Seizures in SCN8A Epileptic Encephalopathy.

Authors:  Eric R Wengert; Raquel M Miralles; Kyle C A Wedgwood; Pravin K Wagley; Samantha M Strohm; Payal S Panchal; Abrar Majidi Idrissi; Ian C Wenker; Jeremy A Thompson; Ronald P Gaykema; Manoj K Patel
Journal:  J Neurosci       Date:  2021-09-20       Impact factor: 6.167

Review 4.  Rational Small Molecule Treatment for Genetic Epilepsies.

Authors:  Ethan M Goldberg
Journal:  Neurotherapeutics       Date:  2021-08-24       Impact factor: 6.088

Review 5.  Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.

Authors:  Lori L Isom; Kelly G Knupp
Journal:  Neurotherapeutics       Date:  2021-08-10       Impact factor: 6.088

6.  Novel HCN1 Mutations Associated With Epilepsy and Impacts on Neuronal Excitability.

Authors:  Changning Xie; Fangyun Liu; Hailan He; Fang He; Leilei Mao; Xiaole Wang; Fei Yin; Jing Peng
Journal:  Front Mol Neurosci       Date:  2022-06-30       Impact factor: 6.261

7.  Development and Validation of a Prediction Model for Early Diagnosis of SCN1A-Related Epilepsies.

Authors:  Andreas Brunklaus; Eduardo Pérez-Palma; Ismael Ghanty; Ji Xinge; Eva Brilstra; Berten Ceulemans; Nicole Chemaly; Iris de Lange; Christel Depienne; Renzo Guerrini; Davide Mei; Rikke S Møller; Rima Nabbout; Brigid M Regan; Amy L Schneider; Ingrid E Scheffer; An-Sofie Schoonjans; Joseph D Symonds; Sarah Weckhuysen; Michael W Kattan; Sameer M Zuberi; Dennis Lal
Journal:  Neurology       Date:  2022-01-24       Impact factor: 11.800

Review 8.  Novel Therapeutics for Neonatal Seizures.

Authors:  Julie M Ziobro; Krista Eschbach; Renée A Shellhaas
Journal:  Neurotherapeutics       Date:  2021-08-12       Impact factor: 6.088

Review 9.  Sodium channelopathies of skeletal muscle and brain.

Authors:  Massimo Mantegazza; Sandrine Cestèle; William A Catterall
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 46.500

Review 10.  A Role for Vasoactive Intestinal Peptide Interneurons in Neurodevelopmental Disorders.

Authors:  Kevin M Goff; Ethan M Goldberg
Journal:  Dev Neurosci       Date:  2021-04-01       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.